autologous anti-CD19 DASH CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-011374
A preparation of autologous T lymphocytes that have been genetically modified and transduced with a gamma-retrovirus vector expressing a second-generation chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 DASH CAR-T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies.
| Identifier | MLC-T-ONC-011374 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CD19 DASH CAR-T cells; CD19 targeted DASH CAR-T cells; autologous anti-CD19 CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011374",
"term": "autologous anti-CD19 DASH CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically modified and transduced with a gamma-retrovirus vector expressing a second-generation chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 DASH CAR-T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies.",
"synonyms": [
"CD19 DASH CAR-T cells",
"CD19 targeted DASH CAR-T cells",
"autologous anti-CD19 CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-cd19-dash-car-t-cells/"
}
Record 2,706 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.